Nancy McFarland

718 total citations
8 papers, 585 citations indexed

About

Nancy McFarland is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, Nancy McFarland has authored 8 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Biochemistry. Recurrent topics in Nancy McFarland's work include Amino Acid Enzymes and Metabolism (3 papers), Bacteriophages and microbial interactions (2 papers) and RNA and protein synthesis mechanisms (2 papers). Nancy McFarland is often cited by papers focused on Amino Acid Enzymes and Metabolism (3 papers), Bacteriophages and microbial interactions (2 papers) and RNA and protein synthesis mechanisms (2 papers). Nancy McFarland collaborates with scholars based in United States and Canada. Nancy McFarland's co-authors include Sydney Kustu, Linda L. McCarter, Emilio García García, G F Ames, B Esmon, Shugang Hui, Germaine Fuh, J A Wells, James H. Bourell and M Brochier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Nancy McFarland

8 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy McFarland United States 7 311 224 113 92 82 8 585
Bunsei Kawakami Japan 12 448 1.4× 121 0.5× 57 0.5× 12 0.1× 33 0.4× 26 580
Wolfgang Klein Germany 10 269 0.9× 103 0.5× 41 0.4× 16 0.2× 19 0.2× 14 514
V. Behrana Jensen United States 14 566 1.8× 201 0.9× 14 0.1× 75 0.8× 7 0.1× 23 876
Bernard Chan United Kingdom 10 322 1.0× 251 1.1× 24 0.2× 8 0.1× 17 0.2× 13 446
Marcus S. Brooke United States 15 185 0.6× 50 0.2× 10 0.1× 29 0.3× 25 0.3× 33 489
Edward D. Renner United States 12 247 0.8× 33 0.1× 11 0.1× 20 0.2× 45 0.5× 22 528
Maksim A. Shlykov United States 11 354 1.1× 95 0.4× 35 0.3× 10 0.1× 77 0.9× 26 701
Dian E. Bohannon United States 7 281 0.9× 271 1.2× 93 0.8× 3 0.0× 25 0.3× 9 566
U. Wiegers Germany 9 311 1.0× 50 0.2× 34 0.3× 7 0.1× 10 0.1× 19 481
H Koch Germany 9 282 0.9× 214 1.0× 33 0.3× 3 0.0× 11 0.1× 29 630

Countries citing papers authored by Nancy McFarland

Since Specialization
Citations

This map shows the geographic impact of Nancy McFarland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy McFarland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy McFarland more than expected).

Fields of papers citing papers by Nancy McFarland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy McFarland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy McFarland. The network helps show where Nancy McFarland may publish in the future.

Co-authorship network of co-authors of Nancy McFarland

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy McFarland. A scholar is included among the top collaborators of Nancy McFarland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy McFarland. Nancy McFarland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cui, Qu, Linda Robinson, Dawn Elston, et al.. (2011). Safety and Tolerability of Varenicline Tartrate (Champix ® /Chantix ® ) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study. AIDS Patient Care and STDs. 26(1). 12–19. 56 indexed citations
2.
Chen, Christina, Brad Snedecor, Julie C. Nishihara, et al.. (2004). High‐level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple‐mutant (degP prc spr) host strain. Biotechnology and Bioengineering. 85(5). 463–474. 63 indexed citations
3.
Chakrabarti, Debasis, et al.. (1996). Control of Islet Intercellular Adhesion Molecule-1 Expression by Interferon-α and Hypoxia. Diabetes. 45(10). 1336–1343. 18 indexed citations
4.
Fuh, Germaine, Michael G. Mulkerrin, S Bass, et al.. (1990). The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain.. Journal of Biological Chemistry. 265(6). 3111–3115. 143 indexed citations
5.
McFarland, Nancy, Linda L. McCarter, S W Artz, & Sydney Kustu. (1982). Characterization of λglnA + phages used as templates for in vitro synthesis of glutamine synthetase. Molecular and General Genetics MGG. 185(1). 152–157. 4 indexed citations
6.
McFarland, Nancy, et al.. (1981). Nitrogen regulatory locus "glnR" of enteric bacteria is composed of cistrons ntrB and ntrC: identification of their protein products.. Proceedings of the National Academy of Sciences. 78(4). 2135–2139. 91 indexed citations
7.
Kustu, Sydney, Nancy McFarland, Shugang Hui, B Esmon, & G F Ames. (1979). Nitrogen control of Salmonella typhimurium: co-regulation of synthesis of glutamine synthetase and amino acid transport systems. Journal of Bacteriology. 138(1). 218–234. 100 indexed citations
8.
Kustu, Sydney, et al.. (1979). Nitrogen control in Salmonella : Regulation by the glnR and glnF gene products. Proceedings of the National Academy of Sciences. 76(9). 4576–4580. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026